Kovitz Investment Group Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $800K | Buy |
5,738
+468
| +9% | +$65.5K | 0.02% | 350 |
|
|
2025
Q4 | $647K | Sell |
5,270
-113,758
| -96% | -$13.8M | 0.01% | 369 |
|
|
2025
Q3 | $13.2M | Buy |
119,028
+106
| +0.1% | +$12K | 0.05% | 277 |
|
|
2025
Q2 | $13.2M | Buy |
118,922
+24,095
| +25% | +$2.56M | 0.06% | 258 |
|
|
2025
Q1 | $10.6M | Sell |
94,827
-3,902
| -4% | -$403K | 0.05% | 256 |
|
|
2024
Q4 | $9.12M | Buy |
98,729
+1,224
| +1% | +$110K | 0.04% | 283 |
|
|
2024
Q3 | $7.13M | Buy |
97,505
+7,801
| +9% | +$595K | 0.05% | 288 |
|
|
2024
Q2 | $6.15M | Sell |
89,704
-266
| -0.3% | -$17.8K | 0.05% | 254 |
|
|
2024
Q1 | $6.59M | Buy |
89,970
+20,395
| +29% | +$1.57M | 0.08% | 173 |
|
|
2023
Q4 | $5.64M | Sell |
69,575
-994
| -1% | -$77.4K | 0.09% | 136 |
|
|
2023
Q3 | $5.29M | Buy |
70,569
+923
| +1% | +$71K | 0.1% | 127 |
|
|
2023
Q2 | $5.37M | Sell |
69,646
-2,396
| -3% | -$191K | 0.08% | 133 |
|
|
2023
Q1 | $5.98M | Buy |
72,042
+3,539
| +5% | +$293K | 0.1% | 122 |
|
|
2022
Q4 | $5.88M | Sell |
68,503
-4,874
| -7% | -$386K | 0.12% | 128 |
|
|
2022
Q3 | $4.53M | Sell |
73,377
-1,336
| -2% | -$84.2K | 0.1% | 152 |
|
|
2022
Q2 | $4.62M | Sell |
74,713
-224
| -0.3% | -$13.9K | 0.1% | 158 |
|
|
2022
Q1 | $4.46M | Sell |
74,937
-9,240
| -11% | -$591K | 0.08% | 177 |
|
|
2021
Q4 | $4.9M | Buy |
84,177
+8,641
| +11% | +$595K | 0.12% | 123 |
|
|
2021
Q3 | $5.28M | Sell |
75,536
-1,518
| -2% | -$107K | 0.11% | 142 |
|
|
2021
Q2 | $5.31M | Sell |
77,054
-1,831
| -2% | -$122K | 0.1% | 147 |
|
|
2021
Q1 | $5.1M | Sell |
78,885
-5,291
| -6% | -$341K | 0.12% | 133 |
|
|
2020
Q4 | $4.9M | Buy |
84,176
+899
| +1% | +$54.2K | 0.12% | 118 |
|
|
2020
Q3 | $5.26M | Sell |
83,277
-1,509
| -2% | -$105K | 0.15% | 107 |
|
|
2020
Q2 | $6.52M | Sell |
84,786
-637
| -0.7% | -$48.8K | 0.2% | 81 |
|
|
2020
Q1 | $6.39M | Sell |
85,423
-5,429
| -6% | -$375K | 0.23% | 72 |
|
|
2019
Q4 | $5.9M | Buy |
90,852
+24,792
| +38% | +$1.61M | 0.17% | 91 |
|
|
2019
Q3 | $4.19M | Sell |
66,060
-352
| -0.5% | -$23K | 0.13% | 125 |
|
|
2019
Q2 | $4.49M | Sell |
66,412
-255
| -0.4% | -$16.8K | 0.14% | 110 |
|
|
2019
Q1 | $4.33M | Buy |
66,667
+452
| +0.7% | +$30K | 0.14% | 115 |
|
|
2018
Q4 | $4.14M | Buy |
66,215
+51,075
| +337% | +$3.57M | 0.16% | 97 |
|
|
2018
Q3 | $1.17M | Buy |
15,140
+290
| +2% | +$21.9K | 0.05% | 87 |
|
|
2018
Q2 | $1.05M | Buy |
+14,850
| New | +$1.05M | 0.05% | 90 |
|
Other funds holding GILD
VCM
VPM
Kovitz Investment Group Partners's GILD Position: Q1 2026 in Review
Kovitz Investment Group Partners increased its Gilead Sciences (GILD) stake by 8.9% in Q1 2026, buying an estimated $65.5K and bringing the position to 5,738 shares worth $800K. The position accounts for 0.02% of the portfolio, ranked #350.
Kovitz Investment Group Partners first reported a position in GILD in Q2 2018 and has held it in 32 quarters since. The position peaked at $13.2M in Q3 2025. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Kovitz Investment Group Partners held 5,738 shares of Gilead Sciences worth $800K as of Q1 2026.
- Kovitz Investment Group Partners bought 468 Gilead Sciences shares in Q1 2026, an estimated $65.5K.
- Gilead Sciences made up 0.02% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #350 holding.
- Kovitz Investment Group Partners first reported a position in Gilead Sciences in Q2 2018 and has held it in 32 quarters since.
- Kovitz Investment Group Partners's Gilead Sciences position peaked at $13.2M in Q3 2025.
- 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.